workflow:
  id: "workflow_pharma_001"
  title: "Drug Development Acceleration Process"
  department: "Research & Development"
  complexity: "high"
  participants: ["Research Director", "Clinical Scientists", "Regulatory Affairs", "Manufacturing", "Quality Control", "Legal"]
  trigger: "New compound identification with therapeutic potential"
  steps:
    - step: 1
      actor: "Research Director"
      action: "Evaluate compound viability and prioritize development candidates"
      tools: ["Research database", "Computational modeling software"]
      duration: "1 week"
      outputs: ["Development candidate selection", "Initial research plan"]
    - step: 2
      actor: "Clinical Scientists"
      action: "Design preclinical studies and toxicology assessments"
      tools: ["Study design software", "Laboratory management systems"]
      duration: "4 weeks"
      outputs: ["Preclinical study protocols", "Safety assessment reports"]
    - step: 3
      actor: "Regulatory Affairs"
      action: "Prepare and submit IND application to FDA"
      tools: ["Regulatory submission software", "Compliance databases"]
      duration: "6 weeks"
      outputs: ["IND submission package", "Regulatory correspondence"]
    - step: 4
      actor: "Clinical Scientists"
      action: "Conduct Phase 1 clinical trials"
      tools: ["Clinical trial management system", "Patient recruitment platforms"]
      duration: "12 weeks"
      outputs: ["Phase 1 trial results", "Safety and dosing data"]
    - step: 5
      actor: "Manufacturing"
      action: "Scale up production for Phase 2 trials"
      tools: ["Process development systems", "Quality control equipment"]
      duration: "8 weeks"
      outputs: ["Clinical trial material batches", "Manufacturing validation reports"]
    - step: 6
      actor: "Quality Control"
      action: "Conduct stability testing and quality assurance"
      tools: ["Analytical instruments", "Quality management software"]
      duration: "4 weeks"
      outputs: ["Stability data", "Quality release certificates"]
  success_criteria: "Successful completion of Phase 2 trials with positive efficacy data"
  failure_modes: ["Adverse safety findings", "Manufacturing scalability issues", "Regulatory approval delays"]